The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of first treatment choice in EGFR mutant non-small cell lung cancer (mNSCLC) patients (pts) per mutation type; retrospective analysis.
 
Jair Bar
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Teva
Research Funding - Boehringer Ingelheim
 
Maya Gottfried
No Relationships to Disclose
 
Julia Dudnik
No Relationships to Disclose
 
Dov Flex
Honoraria - Roche Pharma AG
 
Shoshana P. Keren-Rosenberg
No Relationships to Disclose
 
Abed Agbarya
No Relationships to Disclose
 
Amir Onn
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche Pharma AG
 
Mor Tal Moskovitz
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Natalie Maimon
No Relationships to Disclose
 
Irena Lazarev
No Relationships to Disclose
 
Nir Peled
No Relationships to Disclose
 
Noa Popovits-Hadari
No Relationships to Disclose
 
Haim Biran
Travel, Accommodations, Expenses - BoH; Lilly
 
Damien Urban
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Liv Herscovici
No Relationships to Disclose
 
Mira Wollner
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - MSD; Roche Pharma AG